Roubaix Capital LLC Reduces Holdings in Ralliant Corporation $RAL

Roubaix Capital LLC reduced its stake in Ralliant Corporation (NYSE:RAL) by 10.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 154,619 shares of the company’s stock after selling 18,961 shares during the period. Ralliant accounts for approximately 3.0% of Roubaix Capital LLC’s holdings, making the stock its 8th biggest position. Roubaix Capital LLC’s holdings in Ralliant were worth $6,431,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Viking Global Investors LP acquired a new position in shares of Ralliant during the second quarter valued at approximately $257,200,000. State Street Corp acquired a new stake in Ralliant in the second quarter worth approximately $213,096,000. Millennium Management LLC lifted its position in Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares during the period. Norges Bank bought a new position in Ralliant during the 4th quarter valued at $124,687,000. Finally, Invesco Ltd. boosted its stake in Ralliant by 90.1% during the 3rd quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock valued at $169,309,000 after purchasing an additional 1,835,128 shares in the last quarter.

Analysts Set New Price Targets

RAL has been the topic of several research analyst reports. Morgan Stanley lifted their price target on Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Evercore started coverage on Ralliant in a research note on Tuesday, June 9th. They set an “outperform” rating and a $80.00 target price for the company. Barclays raised their target price on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, May 13th. Wall Street Zen upgraded shares of Ralliant from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Oppenheimer boosted their price target on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $70.80.

Ralliant Trading Up 4.6%

Shares of NYSE:RAL opened at $70.01 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. The stock has a market capitalization of $7.84 billion and a price-to-earnings ratio of -6.40. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $75.41. The company has a 50 day moving average price of $65.21 and a 200 day moving average price of $53.13.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The company had revenue of $534.60 million for the quarter. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, research analysts anticipate that Ralliant Corporation will post 2.64 EPS for the current fiscal year.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 8th were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s payout ratio is presently -1.83%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.